CSI Market
Sign In | Register

Bridgebio Pharma Inc (BBIO) Annual Balance Sheets

Annual · GAAP · USD millions
Access BBIO quarterly Balance Sheets →
The balance sheet data below highlights changes in Bridgebio Pharma Inc's financial position over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent570.12
Available-for-sale Securities, Debt Securities, Current MA17.36
Cash & Short-term Investments587.00
Accounts receivable139.44
Receivables, Long-term Contracts or Programs RE0.00
Inventories26.75
Other Current Assets0.00
Prepaid Expense And Other Assets Current44.07
Total Current Assets797.75
Equipment/Property/Plant Net5.37
Intangible Assets28.08
Long-term investments79.97
Other Assets, Noncurrent104.83
Equity Securities Fv Ni-
Restricted Cash Current-
Operating Lease Right Of Use Asset8.15
Total Assets936.03
Liabilities
Accounts Payable, Current AC36.23
Employee-related Liabilities, Current AC76.70
Other Liabilities, Current175.04
Deferred Revenue, Current DE0.00
Total Current Liabilities287.97
Long-term debt564.57
Total Long-term Debt564.57
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent2,160.07
Accrued Professional And Other Accrued Liabilities Current-
Operating Lease Liability Current6.19
Convertible Senior Notes-
Operating Lease Liability Noncurrent3.81
Total Liabilities3,012.61
Stockholders' Equity
Temporary Equity Carrying Amount Net Including Portion Attributable To Noncontrolling Interests-0.57
Common Stock Value0.20
Treasury Stock Value0.00
Additional Paid In Capital Common Stock2,057.65
Retained Earnings / Accumulated Deficit-3,821.19
Other Equity-322.69
Common Stockholder's Equity-2,086.61
Non-controlling interests & other10.60
Total Stockholder's Equity-2,076.01
Liabilities & Stockholder's Equity936.03
4 historic quarters locked

Sign in to unlock the full Bridgebio Pharma Inc balance sheet history.

Sign In Create Free Account

About Bridgebio Pharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 24, 2026
  • Source: bbio-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001743881-26-000009

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License